The deputy director of the Hubei Provincial Drug Administration, Gong Yongbin, and a group of leader
Date of publication
2024-08-08

Number of visits:

On August 7th, a group of leaders from the Hubei Provincial Drug Administration, including Deputy Director Gong Yongbin and Deputy Director of Device Department Fu Yan, visited Wuhan Youkang Technology Co., Ltd. (hereinafter referred to as: Youkang Technology) for a survey work guidance. The chairman of Youkang Technology, Long Gang, received the visitors and participated in the symposium.

The deputy director of the Hubei Provincial Drug Administration, Gong Yongbin, and a group of leader

In the symposium, both parties conducted thorough exchanges and dialogues regarding the development of the company. Chairman Long Gang introduced and demonstrated urological stone-related products that Yookang Technology has launched, including the guidewire, visual sheath, VCC, SVCC, and electronic mirror. The guidewire series of needle-based surgical systems are mainly used for percutaneous renal surgery, and this technology was included in the national health technology promotion information platform technology selection library in March 2024. The VCC and SVCC series of products are mainly used for ureteral stones, effectively solving problem of ureteral stricture caused by the use of laser lithotripsy instruments in current ureteral rigid mirror surgery. The electronic ureteral mirror is jointly developed by Yookang Technology and the Tongji Hospital of Huazhong University of Science and Technology, and it is a continuation of the classic ureteral flexible mirror. Meanwhile, Chairman Long Gang also reported to the visiting leaders about Yookang Technology's future plans for new technologies and products in such as otolaryngology, hepatobiliary surgery, nephrology, cardiology, vascular surgery, and ESG. During the exchange, Director Gong his team provided on-site guidance on the registration and application of Yookang Technology's products, encouraging the company to strengthen its communication and contact with the provincial at all stages of product development, accelerate product development, and enhance product competitiveness.


The deputy director of the Hubei Provincial Drug Administration, Gong Yongbin, and a group of leader

The on-site research and guidance by the leaders of the Hubei Provincial Drug Administration fully demonstrates their high regard for Yoko Technology, and it also injects strong momentum into the development of Yoko Technology.